 ~ 14-25% of patients who undergo a primary lumpectomy for the treatment of breast cancer require a reoperation due to adverse outcomes like positive surgical margins or early cancer recurrence, adding burden to the patients, providers, and payors.
We analyze the economic impact of patients who require repeat breast tissue resection as part of their treatment following initial resection.
